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Abstract
Introduction: Sandwich immunoassays offer advantages in the clinical laboratory but can yield erroneously low results due to hook (prozone) 
effect, especially with analytes whose concentrations span several orders of magnitude such as ferritin. This study investigated a new approach to 
reduce the likelihood of hook effect in ferritin immunoassays by performing upfront, five-fold dilutions of all samples for ferritin analysis. The im-
pact of this change on turnaround time and costs were also investigated.  
Materials and methods: Ferritin concentrations were analysed in routine clinical practice with and without upfront dilutions on Siemens Centaur® 
XP (Siemens Healthineers, Erlang, Germany) immunoanalysers. In addition, one month of baseline data (1026 results) were collected prior to imple-
menting upfront dilutions and one month of data (1033 results) were collected after implementation.  
Results: Without upfront dilutions, hook effect was observed in samples with ferritin concentrations as low as 86,028 µg/L. With upfront dilutions, 
samples with ferritin concentrations as high as 126,050 µg/L yielded values greater than the measurement interval and would have been diluted 
until an accurate value was obtained. The implementation of upfront dilution of ferritin samples led to a decrease in turnaround time from a median 
of 2 hours and 3 minutes to 1 hour and 18 minutes (P = 0.002). 
Conclusions: Implementation of upfront dilutions of all ferritin samples reduced the possibility of hook effect, improved turnaround time and sa-
ved the cost of performing additional dilutions. 
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While sandwich immunoassays offer a number of 
advantages in the clinical laboratory they also 
have a number of disadvantages, such as the po-
tential for falsely low results due to hook (prozone) 
effect (1). Hook effect describes the paradoxical 
loss of signal that can occur in sandwich immuno-
assays in the presence of high concentrations of 
analyte. Because of this, erroneously low results 
can be reported by the clinical laboratory. The 
hook effect is most commonly encountered with 
analytes that span a wide range of concentrations, 
such as those secreted by tumours including se-
rum free light chains and prolactin (2). Hook effect 
has also been reported in a number of ferritin im-
munoassays (3). Ferritin is an acute phase reactant 
and patients can have concentrations orders of 
magnitude above those commonly seen. High fer-
ritin concentrations are especially common in 
macrophage activation syndrome and adult onset 
Stills disease (4). While rare, patients with these 
conditions can be encountered in tertiary care fa-
cilities such as ours. In these cases, erroneously re-
porting low ferritin concentrations can lead to in-
appropriate patient care.
Clinical laboratories have sought to detect hook 
effect proactively through a variety of means. 
Some have instituted a separate orderable for 
when there is clinical suspicion hook effect might 
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occur (5). Others have employed neural learning 
networks to evaluate reaction curves and detect 
hook effect (6). With regards to lateral flow assays, 
recent efforts have been reported that investigate 
reaction kinetics to reduce hook effect (7). Finally, 
laboratories have performed automatic re-analysis 
of ferritin concentrations that fall within the hook 
range on dilution (3). This short communication 
details our medical centre’s experience in imple-
menting upfront dilution of all samples to reduce 
hook effect in ferritin assays. These dilutions were 
performed automatically by the immunoassay an-
alyser for all samples.   
Materials and methods
Study design
A retrospective, descriptive study was performed 
to determine the impact of implementing upfront 
dilution of all ferritin samples. Prior to this change, 
all ferritin samples were analysed undiluted. Any 
ferritin result which fell above the upper limit of 
the measurement interval (1650 ug/L) had to be 
retrieved, diluted and re-analysed till an accurate 
value was obtained. Implementation of the up-
front dilutions meant that all samples were diluted 
five-fold prior to analysis; no samples were ana-
lysed undiluted.
Subjects
This study was performed at Weill Cornell Medical 
Center between April and May of 2017. All patients 
with ferritin measured in our laboratory as part of 
routine clinical care were included. No samples 
were collected for this study and no individually 
identifiable information was recorded. Thus, ac-
cording to U.S. Department of Health and Human 
Services, this research is not research involving hu-
man subjects (8). Three sample sets were included 
in this study. The first set included two samples for 
which clinicians had expressed concern hook ef-
fect was present. These samples were initially test-
ed without upfront dilutions and re-tested with 
upfront dilutions at clinician request. The second 
sample set included 1026 ferritin results reported 
in the month prior to implementing upfront dilu-
tions and the third set included 1033 ferritin results 
reported after implementing upfront dilutions. 
These sample sets were compared with respect to 
turnaround time and number of samples that 
needed to be retrieved for dilution.    
Methods
Following hospital policies, samples were collect-
ed in serum separator tubes (Becton, Dickinson 
and Company, Franklin Lakes, USA) and sent to the 
clinical laboratory where samples were centri-
fuged for 6 minutes at 1839xg and analysed imme-
diately. Ferritin testing was performed on a Sie-
mens Centaur® XP (Siemens Healthineers, Erlan-
gen, Germany). The coefficient of variation (CV) for 
this assay was under 6% and the reference inter-
vals were 22 – 322 µg/L for men and 10 – 291 µg/L 
for women. Throughout the study period, all qual-
ity assurance protocols were followed in the clini-
cal laboratory including three levels of control eve-
ry twelve hours (BioRad, Hercules, USA). All instru-
ments were operated by certified medical labora-
tory scientists.
For the upfront dilutions, the Centaur® XP was pro-
grammed to automatically perform a five-fold di-
lution using ADVIA Centaur Multi-Diluent 1 (Sie-
mens Healthcare Diagnostics, Eschborn, Germany) 
prior to analysis. No samples were analysed undi-
luted on the instrument. This upfront dilution 
meant that the measuring interval went from 0.5 
– 1650 µg/L to 2.5 – 8250 µg/L. This change was 
necessitated by the upfront five-fold dilution.
Turnaround time was calculated from the time 
samples were received in the laboratory to the 
time results were reported.
Statistical analysis
All data were analysed in Microsoft Excel (Micro-
soft, Redmond, USA). The turnaround times for fer-
ritin results before and after implementing up-
front dilutions were compared to determine if they 
differed significantly. The turnaround times were 
checked for normality using the Shapiro-Wilk test 
of normality. Since the data were not normally dis-
tributed, comparisons were done using the inde-
pendent two-group Mann–Whitney U test to com-
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pare the turnaround times before and after imple-
mentation of the upfront dilutions. All statistical 
calculations were performed using the program R 
(The R Foundation, Vienna, Austria).
Results
Reduction in hook effect
Two samples during the study period were identi-
fied that had very high ferritin concentrations 
(86,028 µg/L and 126,050 µg/L). Without upfront 
dilutions, both of these samples yielded errone-
ously low concentrations within the measurement 
interval and would have been erroneously report-
ed out as 1495 µg/L and 1020 µg/L. When these 
same samples were tested with upfront dilutions, 
they returned concentrations above the upper 
limit of the measurement interval and prompted 
further dilutions. Thus, the upfront dilutions pre-
vent hook effect in samples with ferritin concen-
trations up to 126,050 ug/L. Unfortunately, higher 
ferritin concentrations were not available to test 
the hook effect boundary. 
Turnaround time
The overall turnaround time for all ferritin results 
before and after implementation of upfront dilu-
tions was compared. Before implementation, the 
median turnaround time was 1 hour and 4 min-
utes (N = 1026). After implementation, the median 
turnaround time was 55 minutes (N = 1033). The 
Shapiro-Wilk test of normality showed that the 
data were not normally distributed and so they 
were compared with the independent two-group 
Mann–Whitney U test, which showed they were 
not significantly different (P > 0.05). Since the im-
plementation of upfront dilutions was most likely 
to impact the turnaround time of samples with 
high ferritin concentrations, the turnaround times 
for samples with ferritin results greater than 1650 
µg/L was compared before and after implementa-
tion of upfront dilutions as shown in Figure 1. Be-
fore implementation of the change, there were 37 
samples with high ferritin concentrations and the 
median turnaround time was 2 hours and 3 min-
utes (interquartile range of 133 minutes). After the 
change, there were 34 samples with high ferritin 
concentrations and the median turnaround time 
was 1 hour and 18 minutes (interquartile range of 
73 minutes). These data were not normally distrib-
uted using the Shapiro-Wilk test but the Mann-
Whitney U test showed there was a statistically sig-
nificant decrease in the turnaround time after im-
plementation of the upfront dilutions (P = 0.002).   
Reduction in costs
Without upfront dilutions, 37 of the 1026 samples 
had results above the upper limit of the measure-
ment interval and required dilution to report an 
accurate result. With upfront dilution, only 4 of the 
1033 samples needed to be diluted to obtain an 
accurate result. Workflow estimates showed that 
the process of retrieving samples, making the dilu-
tions and re-running the samples took an average 
of 20 minutes. Since there were 34 fewer dilutions 
with upfront dilutions, this saved 11 person hours 
(34 dilutions x 20 minutes).
Discussion
Without upfront dilutions, it was found that sam-
ples with ferritin concentrations at 86,028 µg/L dis-
played hook effect; this is consistent with the man-
ufacturer’s studies, which report no hook effect 
below 80,000 µg/L. However, this level of hook ef-
Figure 1. Turnaround time for ferritin concentrations greater 
than 1650 µg/L without (N = 37) and with (N = 34) upfront dilu-
tions. A decrease in turnaround time was noted for these sam-
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fect is smaller than what has been reported in the 
literature (3). It is unclear why there is such a dis-
crepancy. With upfront dilutions, hook effect was 
not observed in a sample with ferritin concentra-
tions as high as 126,050 µg/L. Unfortunately, we 
were unable to test the boundary of the hook ef-
fect with upfront dilutions. However, the chance of 
encountering ferritin concentrations above this 
are exceedingly rare. Other approaches to over-
come hook effect have been proposed. Others re-
ported using a separate orderable that tells the lab 
to perform dilutions (5). The disadvantage of this 
approach is that it requires proper selection of the 
orderable by the clinical teams. Our approach 
avoids this by having upfront dilutions pro-
grammed on the instrument. In addition, our ap-
proach is simple and does not require the exper-
tise to implement more complex approaches, such 
as neural learning networks (6).  
A limitation of this study is that this is a single cent-
er study peformed during a limited time period. In 
addition, a small percent of patients benefit from 
this approach. Finally, running each sample dilut-
ed instead of undiluted impacts the lower limit of 
the measurement interval; however, the difference 
between a lower limit of 0.5 and 2.5 ug/L is unlike-
ly to have clinical significance. In conclusion, up-
front dilutions are one approach to overcome 
hook effect in ferritin assays. This approach im-
proves turnaround time for high ferritin concen-
trations and reduces costs.     
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